Secukinumab

secukinumab · Novartis

Drug timelines are a Plus or Pro feature.

96 regulatory and trial events tracked for Secukinumab, covering 2013-01-07 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) [Phase 3]